4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-073405
President and CEO sold 4,272 shares at $9.24 ($39,473)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| AHMED NADIM President and CEO | 2023-12-26 | Sale | −4,272 | $9.24 | $39,473 | 111,550 | D |
| Open-market sales · 4,272 sh · avg $9.24 · $39,473 | |||||||
Loading xslF345X05/ownership.xml…